Aker BioMarine ASA (OSL:AKBM)
Norway · Delayed Price · Currency is NOK 127.40
-2.80 (-2.15%)
Sep 14, 2026, 4:25 PM CET
Aker BioMarine ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,173 | 8,656 | 5,884 | 4,033 | 3,335 | 4,756 | |
Market Cap Growth | 40.31% | 47.13% | 45.89% | 20.94% | -29.89% | -53.79% |
Enterprise Value | 13,007 | 10,398 | 7,308 | 8,170 | 7,246 | 7,421 |
Last Close Price | 127.40 | 98.70 | 67.10 | 25.59 | 21.16 | 30.20 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 2.84 | - | 33.85 | - |
Forward PE | 37.96 | 39.34 | 179.33 | 80.58 | 30.13 | 192.08 |
PS Ratio | 4.96 | 3.94 | 2.60 | 2.03 | 1.22 | 2.06 |
PB Ratio | 8.30 | 5.97 | 3.10 | 1.09 | 0.89 | 1.46 |
P/TBV Ratio | 32.88 | 19.04 | 8.91 | 1.85 | 1.54 | 2.68 |
P/FCF Ratio | - | - | - | 265.14 | - | - |
P/OCF Ratio | - | 204.45 | 42.45 | 8.39 | 22.42 | 207.63 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.78 | 4.73 | 3.23 | 4.10 | 2.65 | 3.21 |
EV/EBITDA Ratio | 58.88 | 30.07 | 17.34 | 77.47 | 12.04 | 21.88 |
EV/EBIT Ratio | 106.75 | 80.59 | - | - | 45.12 | - |
EV/FCF Ratio | - | - | - | 537.11 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.51 | 1.27 | 0.88 | 1.07 | 1.01 | 0.88 |
Debt / EBITDA Ratio | 8.29 | 5.10 | 3.80 | 31.95 | 5.82 | 7.37 |
Debt / FCF Ratio | - | - | - | 262.00 | - | - |
Net Debt / Equity Ratio | 1.36 | 1.15 | 0.79 | 1.00 | 0.95 | 0.85 |
Net Debt / EBITDA Ratio | 7.98 | 4.82 | 3.57 | 35.14 | 5.87 | 8.15 |
Net Debt / FCF Ratio | -13.32 | -78.71 | -25.48 | 243.67 | -14.13 | -4.12 |
Asset Turnover | 0.58 | 0.57 | 0.33 | 0.24 | 0.35 | 0.36 |
Inventory Turnover | 1.11 | 1.22 | 0.88 | 0.65 | 0.97 | 1.38 |
Quick Ratio | 0.90 | 0.76 | 1.21 | 0.83 | 0.84 | 0.93 |
Current Ratio | 2.60 | 2.57 | 3.66 | 2.57 | 2.85 | 3.10 |
Return on Equity (ROE) | -7.00% | -1.80% | -4.50% | -8.67% | 2.67% | -2.15% |
Return on Assets (ROA) | 2.34% | 2.08% | -0.41% | -0.78% | 1.29% | -0.59% |
Return on Invested Capital (ROIC) | 4.61% | 4.21% | -0.78% | -1.40% | 1.88% | -1.07% |
Return on Capital Employed (ROCE) | 4.60% | 4.10% | -1.20% | -1.40% | 2.30% | -1.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.18% | -2.66% | 35.26% | -2.26% | 2.95% | -1.48% |
FCF Yield | -1.23% | -0.24% | -1.00% | 0.38% | -7.50% | -14.10% |
Buyback Yield / Dilution | -143.60% | -0.02% | -0.02% | -0.04% | -0.05% | -12.20% |